CUV 0.66% $15.36 clinuvel pharmaceuticals limited

Food for Thought, page-31

  1. 26,599 Posts.
    lightbulb Created with Sketch. 4533
    Yes, the cancelling of shares is the very definition of a share buy back. The remaining shares consequently aportion a greater equity stake and are therefore more valuable. It’s the opposite of a cash raise when new shares are issued and existing shares become devalued because each share is for a smaller bit of the company. In a way, you weren’t completely wrong saying theoretically they could eventually resell the BB shares equating to no overall cost… in other words, a cash raise exactly equivalent to the cash cost of the buy back… (or they can issue any amount of new shares in a CR subject to ASX rules) but that’s the last thing they should be doing if the company progresses and it would look pretty stewpid. But I have seen companies raise some time after a buy back and you just have to roll your eyes and wonder!
    Last edited by CEOChair: 30/03/24
 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
(20min delay)
Last
$15.36
Change
0.100(0.66%)
Mkt cap ! $766.5M
Open High Low Value Volume
$15.26 $15.46 $15.20 $282.4K 18.44K

Buyers (Bids)

No. Vol. Price($)
2 69 $15.36
 

Sellers (Offers)

Price($) Vol. No.
$15.42 192 4
View Market Depth
Last trade - 11.16am 17/05/2024 (20 minute delay) ?
Last
$15.41
  Change
0.100 ( 1.33 %)
Open High Low Volume
$15.23 $15.44 $15.20 2103
Last updated 11.35am 17/05/2024 ?
CUV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.